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Abstract − Advances in neuro diagnostics based on microwave 
antenna system in terms of a helmet including a set of broad 
band patch antennas is presented. It is shown that 
classification algorithms can be used to detect internal 
bleeding in stroke patients.  The present presentation paper 
also address the challenges to deliver uniform target levels of 
hyperthermia under strict spatial and temporal parameters. 
1 INTRODUCTION 
In Sweden roughly 30 000 people suffer a stroke each 
year and the corresponding number in United States is 
approximately 700 000 persons per year. About 15-
30% becomes permanently disabled, and 20% require 
institutionalization during the first three months after 
the stroke. Approximately 85% of all strokes are 
ischemic (blood cloth induced) and 15% hemorrhagic 
(bleeding) strokes. Stroke comes third among reasons 
for acute death and first among reasons for 
neurological dysfunction in Swedish health care. 
Among stroke survivors, 20% have serious remaining 
dysfunctions. Thrombolysis (blood cloth resolving 
medication), has been shown to improve the outcome 
from ischaemic  stroke, if given in time. This requires 
the ability to quickly distinguish between ischaemic 
and hemorrhagic stroke. For successful thrombolytic 
treatment, new cerebral ischemic events need to be 
identified within 15-30 min. At least partly due to 
these limited time windows, less than 5% of those 
patients that could benefit from this treatment are 
presently receiving it.  The total cost for the society in 
Sweden is estimated to SEK 12 billion per year [1] 
This quick diagnosis of stroke type has been highly 
demanded for a decade as thrombolytic therapy in 
acute stroke treatment became internationally 
approved. Thrombolytic therapy can be used very 
successfully for ischemic stroke but have disastrous 
effect if given to patients suffering from 
haemorrhagic stroke, thus making it extremely 
important prior treatment to rule out haemorrhagic 
stroke. The effect of the therapy is better the sooner 
the treatment is initiated since more brain tissue is 
rescued the sooner the blood flow is restored. 
Thrombolytic treatment can not be started if more 
than 3h have passed since the first symptoms as the 
risk for causing a bleeding in the damaged area has 
become too high.   
 
Cancer is a worldwide leading cause of death, only 
preceded by cardiovascular diseases. In a total of 58 
million deaths caused by disease worldwide in 2005, 
cancer accounted for 7.6 million (13%). The situation 
in Sweden is similar with cancer he second most 
common cause of death in 2004. The total mortality 
trend is falling. In the 1960s around 40% of those 
diagnosed in Sweden with cancer had a 5-year survival 
rate, but by 1994-1996 this figure had risen to 60%. 
The figures show similar development for most cancer 
sites, even though the mortality trend in lung cancer 
for women has increased during the period. However, 
improved screening and earlier diagnosis may have 
done more to improve the treatment success rate than 
improvements in treatment modalities. To date, 
surgery is often still the most effective cancer 
treatment, although radiation and chemotherapy are 
becoming increasingly effective. Radiation treatment 
is likely to become even more effective as the 
techniques for imaging and targeting of cancer cells 
improve. However, the degree of success and progress 
in cancer treatment comes at a cost. In the year 2000, 
cancer was estimated to account for almost 6% of the 
entire treatment of cost of all diseases. It is thus clear 
that in order to improve the cancer cure-rates further, 
conventional oncological methods need to be 
combined with new treatment modalities. 
Microwave hyperthermia has the potential to improve 
cancer treatment outcome considerably for many 
cancer forms. However, despite many positive 
clinical studies and the solid biological basis, there 
are challenges in the ability to deliver uniform target 
levels of hyperthermia under strict spatial and 
temporal parameters. This challenge is the focus of 
the present presentation.  
2 NEURO DIAGNOSTICS 
Advances in neuro diagnostics based on microwave 
antenna system in terms of a helmet including a set of 
broad band patch antennas is presented. It is shown 
that classification algorithms can be used to detect 
internal bleeding in stroke patients. The diagnostic of 
stroke patients suffer from a number of serious 
limitations. The most severe problem is that the 
diagnosis often takes too long time to establish. In 80% 
of the patients the stroke are caused by a clot, which 
can be treated with clot-resolving medication if given 
in time. Unfortunately most patients will not receive 
their diagnosis in time to save the brain from damage 
due to delays in the chain of care. This is because it 
needs to be established that the stroke is not caused by 
hemorrhage. It has been suggested that microwave 
  
based systems can solve some of these outstanding 
problems. For this purpose we have developed a 
microwave helmet and performed an initial clinical 
study on 20 stroke patients. Using classification 
algorithms we have obtained encouraging results, but 
more patients have to be measured before any 
definitive conclusions can.  The stroke detection 
helmet is built by 10 patch antennas that have been 
mounted in a helmet and the multistatic scattering 
matrix is measures at a large number of frequencies. 
The measured scattering coefficients are then used as 
input for the classifier algorithm. This measurement 
strategy is similar to what is commonly used in 
microwave tomography experiments. The multistatic 
matrix is measured using each antenna both as 
transmitter as well as receiver. A two port network 
analyzer is used as the transmitting and receiving unit. 
To fully control the experiment a multiplexer module 
is used to automatically connect and disconnect the 
different combinations of antenna pairs to the network 
analyzer. A particular problem with the helmet is that 
it is rigid whereas the size and shape of different 
patients varies. To fit the antenna to individual patients 
the solution is to mount flexible plastic bags inside the 
helmet that can be filled with water. The purpose of the 
water bags is to fill up the space between the antennas 
and the skull but also to provide impedance matching 
between the antenna and the skull. If the antennas were 
just left with an air gap between the antenna and the 
skull the differences in intrinsic impedances between 
skin and air would cause a strong reflection at the 
surface of the skin, thereby preventing a large portion 
of the signal to penetrate into the skull. Only the signal 
penetrating will be useful in stroke detection and a 
weak signal into the skull means a weak signal out and 
consequently also a low signal to noise ratio.  We are 
currently investing data driven approaches to develop 
detection and classification algorithms where the 
 scattering measurements are treated as 
multidimensional signal samples. Based on labeled 
data we construct the classifier by extracting features 
from the high dimensional data and then project them 
to lower dimensions suitable for discrimination 
between the classes. Subspace based techniques both 
in classical euclidean spaces as well as in higher 
dimensional linear spaces has been successful in 
medical applications detecting bleeding stroke.  Also, 
In Western Sweden, roughly 650 people/year suffer a 
cerebral transient ischemic attack (TIA). Common 
symptoms of TIA are transient hemiparesis, dysfasia, 
sensory disturbances and/or blindness. TIA constitutes 
a clear warning of impending stroke, occurring after 
approx. 15-20% of TIAs. As many as 2/3 of 
manifested strokes can be prevented if the patients 
receive early treatment with vascular surgery and/or 
trombolytic treatment. However, trombolytic treatment 
can only be performed during a critical and narrow 
time window. Thus, successful active treatment of 
TIA/impending stroke depends on sensitive continuous 
monitoring of brain function before and after 
treatment. The hypothesis, to be tested in the project, is 
that this role can be played by a portable microwave 
based monitoring system. 
 
3 CANCER TREATMENT 
During the last decade clinical studies have 
demonstrated the ability of microwave hyperthermia to 
dramatically enhance cancer patient survival. 
However, the clinical results are limited with respect 
to cancer forms a tumor positions. We believe that this 
is partly du to limitations in technology and 
algorithms. The fundamental challenge is to 
adequately heat deep-seated tumors while preventing 
surrounding healthy tissue from undesired heating and 
damage. This challenge needs to be resolved for 
hyperthermia to develop into standard treatment for a 
larger number of tumours. Specifically, the challenge 
to deliver power levels with spatial control, the 
challenge of patient treatment planning, and the 
challenge of temperature measurements need to be 
resolved.  While treatment planning can somewhat 
limit the need for temperature measurements, quality 
assurance and effectiveness of the treatment can still 
benefit from high quality temperature monitoring.  It is 
useful both for feedback control and for evaluation of 
the clinical efficiency. Invasive measurements are still 
regarded by many as the gold standard but it suffers 
from incomplete information about highly 
inhomogeneous temperature distributions. The most 
clinically advanced approach of non-invasive 
thermometry is MRI techniques which, while 
clinically feasible, are likely to be too expensive to be 
long term clinical solutions. We are therefore instead 
developing a method to measure temperature with 
microwaves. Knowledge of the temperature 
characteristics of biological tissues together with the 
geometrical constraint obtained from the segmented 
patient specific models are coupled to an existing 
optimization based microwave tomography method. 
The method is tested using the Chalmers microwave 
tomography system.  
 
